TXMD
TherapeuticsMD, Inc.
Price Chart
Latest Quote
$2.27
-0.02 (-0.87%)
Current Price
| Previous Close | $2.29 |
| Open | $2.26 |
| Day High | $2.32 |
| Day Low | $2.26 |
| Volume | 16,817 |
Stock Information
| Shares Outstanding | 11.57M |
| Total Debt | $5.83M |
| Cash Equivalents | $8.42M |
| Revenue | $3.35M |
| Net Income | $86K |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $26.27M |
| P/E Ratio | 227.00 |
| EPS (TTM) | $0.01 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $23.92M |
| Sales | $3.35M |
| Income | $86K |
| Book/sh | $2.33 |
| Cash/sh | $0.73 |
| Employees | 1 |
Financial Ratios
| Quick Ratio | 2.50 |
| Current Ratio | 3.11 |
| Debt/Eq | 21.62 |
Returns & Margins
| ROA | -2.95% |
| ROE | 0.32% |
| Gross Margin | 100.00% |
| Operating Margin | -28.45% |
| Profit Margin | 5.34% |
Ownership
| Insider Ownership | 7.45% |
| Institutional Ownership | 34.01% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 6.49 |
| P/S | 7.84 |
| P/B | 0.97 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $2.07 |
| SMA50 | $2.07 |
| SMA200 | $1.82 |
| RSI | 58.89 |
| ATR | 0.1443 |
| Shares Float | 9.49M |
| Short Float | 0.61% |
| Short Ratio | 2.60 |
| Volatility | 0.60 |
| Rel Volume | 0.26 |
Performance History
| Week | +22.04% |
| Month | +12.38% |
| Quarter | +2.25% |
| 6 Months | +33.53% |
| YTD | +37.58% |
| Year | +110.19% |
| 3 Years | -41.79% |
| 5 Years | -96.61% |
| 10 Years | -99.48% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $2.27 | 16,800 |
| 2026-06-16 | $2.29 | 20,900 |
| 2026-06-15 | $2.28 | 118,700 |
| 2026-06-12 | $2.20 | 259,200 |
| 2026-06-11 | $1.82 | 53,700 |
| 2026-06-10 | $1.86 | 39,900 |
| 2026-06-09 | $1.88 | 87,400 |
| 2026-06-08 | $1.88 | 174,500 |
| 2026-06-05 | $1.99 | 132,400 |
| 2026-06-04 | $2.00 | 11,800 |
| 2026-06-03 | $1.97 | 44,100 |
| 2026-06-02 | $2.04 | 178,400 |
| 2026-06-01 | $2.12 | 14,800 |
| 2026-05-29 | $2.14 | 14,600 |
| 2026-05-28 | $2.11 | 24,700 |
| 2026-05-27 | $2.11 | 27,200 |
| 2026-05-26 | $2.11 | 20,600 |
| 2026-05-22 | $2.12 | 13,400 |
| 2026-05-21 | $2.11 | 12,900 |
| 2026-05-20 | $2.08 | 10,100 |
| 2026-05-19 | $2.04 | 6,800 |
| 2026-05-18 | $2.02 | 12,000 |
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $3,022,000 | $1,761,000 | $1,302,000 | $69,963,000 |
| Operating Revenue | $3,022,000 | $1,761,000 | $1,302,000 | $69,963,000 |
| Reconciled Cost Of Revenue | - | - | $22,000 | $1,390,000 |
| Cost Of Revenue | - | - | $0 | $1,397,000 |
| Expenses | ||||
| Total Expenses | $7,236,000 | $6,605,000 | $9,825,000 | $59,300,000 |
| Other Income Expense | $3,419,000 | $2,366,000 | $781,000 | $-9,589,000 |
| Other Non Operating Income Expenses | $3,595,000 | $3,634,000 | $781,000 | $-117,000 |
| Net Non Operating Interest Income Expense | $142,000 | $135,000 | - | - |
| Operating Expense | $7,236,000 | $6,605,000 | $9,825,000 | $57,903,000 |
| General And Administrative Expense | $6,852,000 | $6,096,000 | - | $57,903,000 |
| Selling And Marketing Expense | - | - | - | $0 |
| Interest Expense | - | - | - | - |
| Total Other Finance Cost | - | - | - | - |
| Interest Expense Non Operating | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-653,000 | $-2,312,000 | $-7,699,000 | $1,074,000 |
| Net Interest Income | $142,000 | $135,000 | - | - |
| Interest Income | $142,000 | $135,000 | - | - |
| Normalized Income | $-477,000 | $-1,060,484 | $-7,699,000 | $10,546,000 |
| Net Income From Continuing And Discontinued Operation | $-569,000 | $-2,181,000 | $-10,278,000 | $111,997,000 |
| Total Operating Income As Reported | $-4,390,000 | $-6,112,000 | $-8,523,000 | $1,191,000 |
| Net Income Common Stockholders | $-569,000 | $-2,181,000 | $-10,278,000 | $111,997,000 |
| Net Income | $-569,000 | $-2,181,000 | $-10,278,000 | $111,997,000 |
| Net Income Including Noncontrolling Interests | $-569,000 | $-2,181,000 | $-10,278,000 | $111,997,000 |
| Net Income Discontinuous Operations | $84,000 | $131,000 | $-2,579,000 | $110,923,000 |
| Net Income Continuous Operations | $-653,000 | $-2,312,000 | $-7,699,000 | $1,074,000 |
| Pretax Income | $-653,000 | $-2,343,000 | $-7,742,000 | $1,074,000 |
| Special Income Charges | $-176,000 | $-1,268,000 | $0 | $-9,472,000 |
| Interest Income Non Operating | $142,000 | $135,000 | - | - |
| Operating Income | $-4,214,000 | $-4,844,000 | $-8,523,000 | $10,663,000 |
| Depreciation Amortization Depletion Income Statement | $384,000 | $509,000 | $922,000 | $1,193,000 |
| Depreciation And Amortization In Income Statement | $384,000 | $509,000 | $922,000 | $1,193,000 |
| Gross Profit | - | - | $1,302,000 | $68,566,000 |
| Per Share | ||||
| Diluted EPS | $-0.05 | $-0.19 | $-0.98 | $11.96 |
| Basic EPS | $-0.05 | $-0.19 | $-0.98 | $12.41 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-16,484 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,845,000 | $-2,296,000 | $-7,601,000 | $21,335,000 |
| Total Unusual Items | $-176,000 | $-1,268,000 | $0 | $-9,472,000 |
| Total Unusual Items Excluding Goodwill | $-176,000 | $-1,268,000 | $0 | $-9,472,000 |
| Reconciled Depreciation | $1,193,000 | $1,280,000 | $922,000 | $1,200,000 |
| EBITDA (Bullshit earnings) | $-3,021,000 | $-3,564,000 | $-7,601,000 | $11,863,000 |
| EBIT | $-4,214,000 | $-4,844,000 | $-8,523,000 | $10,663,000 |
| Diluted Average Shares | $11,569,000 | $11,532,000 | $10,441,000 | $9,366,000 |
| Basic Average Shares | $11,569,000 | $11,532,000 | $10,441,000 | $9,028,000 |
| Diluted NI Availto Com Stockholders | $-569,000 | $-2,181,000 | $-10,278,000 | $111,997,000 |
| Tax Provision | $0 | $-31,000 | $-43,000 | $0 |
| Impairment Of Capital Assets | $176,000 | $1,268,000 | $0 | - |
| Selling General And Administration | $6,852,000 | $6,096,000 | $8,903,000 | $56,710,000 |
| Other Gand A | $6,852,000 | $6,096,000 | - | $57,903,000 |
| Restructuring And Mergern Acquisition | - | - | $0 | $9,472,000 |
| Research And Development | - | - | - | $0 |
Fetched: 2026-06-08
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $23,115,000 | $23,049,000 | $23,189,000 | $28,200,000 |
| Total Assets | $37,656,000 | $38,822,000 | $43,309,000 | $90,458,000 |
| Total Non Current Assets | $23,211,000 | $26,563,000 | $31,513,000 | $35,107,000 |
| Other Non Current Assets | $444,000 | $130,000 | $58,000 | $253,000 |
| Non Current Accounts Receivable | $13,713,000 | $16,010,000 | $18,484,000 | $20,253,000 |
| Goodwill And Other Intangible Assets | $3,761,000 | $4,321,000 | $6,098,000 | $6,943,000 |
| Other Intangible Assets | $3,761,000 | $4,321,000 | $6,098,000 | $6,943,000 |
| Current Assets | $14,445,000 | $12,259,000 | $11,796,000 | $55,351,000 |
| Other Current Assets | $3,437,000 | $3,638,000 | $4,035,000 | $6,034,000 |
| Receivables | $3,525,000 | $3,562,000 | $3,090,000 | $0 |
| Other Receivables | $3,525,000 | $3,562,000 | $3,090,000 | - |
| Cash Cash Equivalents And Short Term Investments | $7,483,000 | $5,059,000 | $4,327,000 | $38,067,000 |
| Cash And Cash Equivalents | $7,483,000 | $5,059,000 | $4,327,000 | $38,067,000 |
| Assets Held For Sale Current | - | $0 | $344,000 | $0 |
| Restricted Cash | - | - | $0 | $11,250,000 |
| Prepaid Assets | - | - | $253,000 | $1,167,000 |
| Cash Financial | - | - | - | $38,067,000 |
| Inventory | - | - | - | - |
| Accounts Receivable | - | - | - | - |
| Allowance For Doubtful Accounts Receivable | - | - | - | - |
| Gross Accounts Receivable | - | - | - | - |
| Debt | ||||
| Total Debt | $6,097,000 | $7,175,000 | $8,005,000 | $8,759,000 |
| Long Term Debt And Capital Lease Obligation | $5,122,000 | $5,542,000 | $6,532,000 | $7,369,000 |
| Current Debt And Capital Lease Obligation | $975,000 | $1,633,000 | $1,473,000 | $1,390,000 |
| Net Debt | - | - | - | - |
| Current Debt | - | - | - | - |
| Other Current Borrowings | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $10,780,000 | $11,452,000 | $14,022,000 | $55,315,000 |
| Total Non Current Liabilities Net Minority Interest | $5,995,000 | $6,286,000 | $7,168,000 | $8,476,000 |
| Other Non Current Liabilities | $873,000 | $744,000 | $636,000 | $1,107,000 |
| Current Liabilities | $4,785,000 | $5,166,000 | $6,854,000 | $46,839,000 |
| Other Current Liabilities | $2,667,000 | $2,781,000 | $3,694,000 | $25,831,000 |
| Payables And Accrued Expenses | $1,143,000 | $752,000 | $1,687,000 | $18,607,000 |
| Payables | $377,000 | $258,000 | $27,000 | $2,162,000 |
| Accounts Payable | $377,000 | $258,000 | $27,000 | $2,162,000 |
| Current Deferred Liabilities | - | - | $0 | $1,011,000 |
| Equity | ||||
| Common Stock Equity | $26,876,000 | $27,370,000 | $29,287,000 | $35,143,000 |
| Total Equity Gross Minority Interest | $26,876,000 | $27,370,000 | $29,287,000 | $35,143,000 |
| Stockholders Equity | $26,876,000 | $27,370,000 | $29,287,000 | $35,143,000 |
| Retained Earnings | $-952,391,000 | $-951,822,000 | $-949,641,000 | $-939,363,000 |
| Other | ||||
| Ordinary Shares Number | $11,574,362 | $11,532,432 | $11,532,443 | $9,498,000 |
| Share Issued | $11,574,362 | $11,532,432 | $11,532,443 | $9,498,000 |
| Tangible Book Value | $23,115,000 | $23,049,000 | $23,189,000 | $28,200,000 |
| Invested Capital | $26,876,000 | $27,370,000 | $29,287,000 | $35,143,000 |
| Working Capital | $9,660,000 | $7,093,000 | $4,942,000 | $8,512,000 |
| Capital Lease Obligations | $6,097,000 | $7,175,000 | $8,005,000 | $8,759,000 |
| Total Capitalization | $26,876,000 | $27,370,000 | $29,287,000 | $35,143,000 |
| Additional Paid In Capital | $979,256,000 | $979,181,000 | $978,917,000 | $974,497,000 |
| Capital Stock | $11,000 | $11,000 | $11,000 | $9,000 |
| Common Stock | $11,000 | $11,000 | $11,000 | $9,000 |
| Long Term Capital Lease Obligation | $5,122,000 | $5,542,000 | $6,532,000 | $7,369,000 |
| Current Capital Lease Obligation | $975,000 | $1,633,000 | $1,473,000 | $1,390,000 |
| Current Accrued Expenses | $766,000 | $494,000 | $1,660,000 | $16,445,000 |
| Net PPE | $5,293,000 | $6,102,000 | $6,873,000 | $7,658,000 |
| Gross PPE | $5,293,000 | $6,102,000 | $6,873,000 | $10,103,000 |
| Other Properties | $5,293,000 | $6,102,000 | $6,873,000 | $7,580,000 |
| Accumulated Depreciation | - | - | $-2,522,000 | $-2,445,000 |
| Leases | - | - | $49,000 | $49,000 |
| Machinery Furniture Equipment | - | - | $2,473,000 | $2,474,000 |
| Properties | - | - | $0 | $0 |
| Preferred Stock | - | - | - | $0 |
| Finished Goods | - | - | - | - |
| Work In Process | - | - | - | - |
| Raw Materials | - | - | - | - |
Fetched: 2026-06-08
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $2,454,000 | $1,170,000 | $-23,081,000 | $9,004,000 |
| Operating Activities | ||||
| Operating Cash Flow | $2,454,000 | $1,170,000 | $-23,081,000 | $9,359,000 |
| Cash Flow From Continuing Operating Activities | $2,454,000 | $1,170,000 | $-23,081,000 | $9,366,000 |
| Cash From Discontinued Operating Activities | - | - | - | $-13,437,000 |
| Investing Activities | ||||
| Investing Cash Flow | - | - | $0 | $-355,000 |
| Cash Flow From Continuing Investing Activities | - | - | $0 | $-355,000 |
| Capital Expenditure | - | - | - | $-355,000 |
| Cash From Discontinued Investing Activities | - | - | - | $223,834,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | - | $0 | $3,151,000 | $24,152,000 |
| Financing Cash Flow | - | $0 | $3,151,000 | $-235,206,000 |
| Cash Flow From Continuing Financing Activities | - | $0 | $3,151,000 | $-235,206,000 |
| Net Common Stock Issuance | - | $0 | $3,151,000 | $2,468,000 |
| Common Stock Issuance | - | $0 | $3,151,000 | $2,468,000 |
| Repurchase Of Capital Stock | - | - | $0 | $-38,657,000 |
| Net Preferred Stock Issuance | - | - | $0 | $-16,973,000 |
| Preferred Stock Issuance | - | - | $0 | $21,684,000 |
| Cash From Discontinued Financing Activities | - | - | - | $0 |
| Net Other Financing Charges | - | - | - | $-1,269,000 |
| Other | ||||
| End Cash Position | $7,483,000 | $5,059,000 | $4,327,000 | $49,317,000 |
| Beginning Cash Position | $5,059,000 | $4,327,000 | $49,317,000 | $65,122,000 |
| Changes In Cash | $2,424,000 | $732,000 | $-44,990,000 | $-15,805,000 |
| Cash Flow From Discontinued Operation | $-30,000 | $-438,000 | $-25,060,000 | $210,397,000 |
| Change In Working Capital | $1,663,000 | $670,000 | $-17,446,000 | $-4,086,000 |
| Change In Other Current Liabilities | $-949,000 | $-882,000 | $-471,000 | $-121,000 |
| Change In Other Current Assets | $2,020,000 | $1,930,000 | $-1,126,000 | $-7,636,000 |
| Change In Payables And Accrued Expense | $391,000 | $-775,000 | $-17,848,000 | $3,051,000 |
| Change In Accrued Expense | $272,000 | $-1,006,000 | $-15,713,000 | $4,262,000 |
| Change In Payable | $119,000 | $231,000 | $-2,135,000 | $-1,211,000 |
| Change In Account Payable | $119,000 | $231,000 | $-2,135,000 | $-1,211,000 |
| Change In Prepaid Assets | $201,000 | $397,000 | $1,999,000 | $620,000 |
| Stock Based Compensation | $75,000 | $264,000 | $1,271,000 | $11,572,000 |
| Asset Impairment Charge | $176,000 | $1,268,000 | $0 | - |
| Depreciation Amortization Depletion | $1,193,000 | $1,280,000 | $922,000 | $1,200,000 |
| Depreciation And Amortization | $1,193,000 | $1,280,000 | $922,000 | $1,200,000 |
| Depreciation | $1,193,000 | $1,280,000 | $100,000 | $600,000 |
| Net Income From Continuing Operations | $-653,000 | $-2,312,000 | $-7,699,000 | $1,074,000 |
| Other Non Cash Items | - | $-219,000 | $-129,000 | $-401,000 |
| Repayment Of Debt | - | - | $0 | $-219,432,000 |
| Interest Paid Supplemental Data | - | - | $0 | $13,545,000 |
| Preferred Stock Payments | - | - | $0 | $-38,657,000 |
| Net Issuance Payments Of Debt | - | - | $0 | $-219,432,000 |
| Net Long Term Debt Issuance | - | - | $0 | $-219,432,000 |
| Long Term Debt Payments | - | - | $0 | $-219,432,000 |
| Net Intangibles Purchase And Sale | - | - | $0 | $-355,000 |
| Amortization Cash Flow | - | - | $800,000 | $600,000 |
| Amortization Of Intangibles | - | - | $800,000 | $600,000 |
| Proceeds From Stock Option Exercised | - | - | - | $0 |
| Net Short Term Debt Issuance | - | - | - | $-219,432,000 |
| Short Term Debt Payments | - | - | - | $-219,432,000 |
| Purchase Of Intangibles | - | - | - | $-355,000 |
| Net PPE Purchase And Sale | - | - | - | $0 |
| Purchase Of PPE | - | - | - | $0 |
| Issuance Of Debt | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
| Change In Inventory | - | - | - | - |
| Change In Receivables | - | - | - | - |
| Changes In Account Receivables | - | - | - | - |
| Provisionand Write Offof Assets | - | - | - | - |
Fetched: 2026-06-08